Transcription Factor NRF2 Participates in Cell Cycle Progression at the Level of G1/S and Mitotic Checkpoints
Transcription factor NRF2 is a master regulator of the multiple cytoprotective responses that confer growth advantages on a cell. However, its participation in the mechanisms that govern the cell division cycle has not been explored in detail. In this study, we used several standard methods of synch...
Main Authors: | Diego Lastra, Maribel Escoll, Antonio Cuadrado |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/11/5/946 |
Similar Items
-
Immune checkpoint inhibitor-induced encephalitis with dostarlimab in two patients: Case series
by: Sina Marzoughi, et al.
Published: (2021-12-01) -
Immune-Checkpoint Inhibitor-Induced Fulminant Myocarditis and Cardiogenic Shock
by: Osnat Itzhaki Ben Zadok, MD, MS, et al.
Published: (2019-09-01) -
Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice
by: Edoardo G. Giannini, et al.
Published: (2019-10-01) -
Management of Immune Checkpoint Inhibitor Toxicities
by: Durrechou Q, et al.
Published: (2020-09-01) -
To RTK points in CZEPOS network
by: Zdeněk Nevosád
Published: (2007-06-01)